Amneal: brands it owns and its ownership tree
Amneal (NASDAQ: AMRX) is a publicly listed company headquartered in Bridgewater, United States that owns 6 consumer brands and makes and sells 1 consumer brand under licence without owning the name.[1]
Amneal Pharmaceuticals is a Bridgewater, New Jersey drugmaker whose 10-K for 2025 describes three segments: Affordable Medicines (generics, injectables and biosimilars), Specialty (branded products for central nervous system and endocrine disorders) and AvKARE, a pharmaceutical distributor. It had over 8,500 employees at 31 December 2025 and operates in the United States, India and Ireland.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
divestitures recorded
Company facts
- Legal name
- Amneal Pharmaceuticals, Inc.
- Type
- publicly listed company · see all publicly listed company owners
- Headquarters
- 🇺🇸 Bridgewater, United States
- Tickers
- NASDAQ: AMRX
- SEC CIK
- 0001723128
- Website
- www.amneal.com
- Last verified
- · 1 sources
Amneal in numbers
- Amneal owns 6 consumer brands tracked here across 1 top-level categories; the largest is healthcare & pharma with 6 brands.[1]
Everything Amneal owns
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Full-screen interactive tree → · Download as infographic
Brand portfolio by category
Minority stakes, joint ventures and licences
Recent changes to this record
Official recalls involving Amneal products
19 recall notices from government regulators matched to Amneal. Each applies to the specific products, sizes and lot codes named in the notice, not to every product sold under the name.
- Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08907, NDC 69238-2452-3. — FDA, · Class II
Reason given: Defective Container; packets were found to be either empty or partially full.
Recalling firm: Amneal Pharmaceuticals, LLC
- Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal… — FDA, · Class II
Reason given: Defective Delivery System: Possibility of no medication in the prefilled pen.
Recalling firm: Amneal Pharmaceuticals of New York, LLC
- Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Oral Solid Dosage Unit, Ahmedabad 382213,… — FDA, · Class III
Reason given: Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
Recalling firm: Amneal Pharmaceuticals, LLC
- traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India,… — FDA, · Class II
Reason given: Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term…
Recalling firm: Amneal Pharmaceuticals, LLC
- Magnesium Sulfate in Water for Injection, 4g/100 mL (40mg/mL) IV bag, further packaged in cartons of 12 x 100 mL IV bags, Rx only, Manufactured by: Amneal… — FDA, · Class I
Reason given: Product mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually contained an IV bag of Tranexamic Acid instead.
Recalling firm: Amneal Pharmaceuticals, LLC
Matched automatically from FDA, USDA FSIS, UK Food Standards Agency and CPSC records only when the recalling firm corresponds to this ownership record and, for a brand, the brand name appears in the product description. Check the linked notice for exact products and lots. Method.
Frequently asked questions
What brands does Amneal own?
Amneal owns 6 consumer brands tracked here, including Rytary, AvKARE, Amneal, Brekiya, Crexont and AvPAK.
Is Amneal an American company?
Yes. Amneal is headquartered in Bridgewater, United States.
Who owns Amneal?
Amneal is a publicly listed company owned by its shareholders; it trades as AMRX on the NASDAQ.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Amneal Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27 — SEC EDGAR, SEC Form 10-K, published 27 February 2026; retrieved 14 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.